Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | CRHBP | P24387 | 1/20 | 0.37 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.37 |
| ▸ | S100B | P04271 | 1/20 | 0.36 |
| ▸ | CFTR | P13569 | 1/20 | 0.35 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29278568 | 1.00 | CYP3A4 (0.45) | CYP3A4TDP1ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL22044330 | 0.91 | CYP3A4 (0.50) | CYP3A4TDP1ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL5166514 | 0.89 | CYP3A4 (0.54) | CYP3A4TDP1ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL30749457 | 0.89 | CYP3A4 (0.54) | CYP3A4TDP1ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL14878840 | 0.87 | CYP3A4 (0.35) | CYP3A4TDP1ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL5495313 | 0.86 | ALDH1A1 (0.50) | CYP3A4TDP1ALDH1A1TSHRMAPK1 | |
| SCHEMBL31409207 | 0.86 | ALDH1A1 (0.46) | CYP3A4TDP1ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL13070208 | 0.86 | ALDH1A1 (0.46) | CYP3A4TDP1ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL109819 | 0.86 | CYP3A4 (0.46) | CYP3A4TDP1ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL30602820 | 0.86 | CYP3A4 (0.46) | CYP3A4TDP1ALDH1A1TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112300975-B | Low-pathogenicity mutant strain of pogostemon cablin ralstonia solanacearum and application thereof | 广州中医药大学(广州中医药研究院) | 2022-06-14 | — | — | CN | claimed |
| CN-112300975-A | Low-pathogenicity mutant strain of pogostemon cablin ralstonia solanacearum and application thereof | 广州中医药大学(广州中医药研究院) | 2021-02-02 | — | — | CN | claimed |
| CN-112300975-B | Low-pathogenicity mutant strain of pogostemon cablin ralstonia solanacearum and application thereof | 广州中医药大学(广州中医药研究院) | 2022-06-14 | — | — | CN | disclosed |
| CN-112226384-B | Pathogenic strain causing patchouli bacterial wilt and application thereof | 广州中医药大学(广州中医药研究院) | 2022-05-10 | — | — | CN | disclosed |
| CN-112300975-A | Low-pathogenicity mutant strain of pogostemon cablin ralstonia solanacearum and application thereof | 广州中医药大学(广州中医药研究院) | 2021-02-02 | — | — | CN | disclosed |
| CN-112226384-A | Pathogenic strain causing patchouli bacterial wilt and application thereof | 广州中医药大学(广州中医药研究院) | 2021-01-15 | — | — | CN | disclosed |
| US-20200172470-A1 | NOVEL (POLY)AMINE COMPOUND, RESIN AND CURED PRODUCT | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2020-06-04 | — | — | US | disclosed |
| EP-3659996-A1 | NOVEL (POLY)AMINE COMPOUND, RESIN, AND CURED PRODUCT | Mitsubishi Gas Chemical Company, Inc. (JP) | 2020-06-03 | — | — | EP | disclosed |
| EP-2049599-B1 | BASIC BISAZO COMPOUNDS | ARCHROMA IP GMBH (CH) | 2017-02-22 | — | — | EP | disclosed |
| US-8921564-B2 | Basic bisazo compounds | CLARIANT FINANCE (BVI) LTD. (VG) | 2014-12-30 | — | — | US | disclosed |
| US-8921564-B2 | Basic bisazo compounds | CLARIANT FINANCE (BVI) LTD. (VG) | 2014-12-30 | — | — | US | disclosed |
| EP-2251387-A1 | Acidic azo dyes | Clariant International Ltd. (CH) | 2010-11-17 | — | — | EP | disclosed |
| EP-2251383-A1 | Organic compounds | Clariant International Ltd. (CH) | 2010-11-17 | — | — | EP | disclosed |
| EP-2251384-A1 | Pyrazolone monoazo dyes | Clariant International Ltd. (CH) | 2010-11-17 | — | — | EP | disclosed |
| EP-2251383-A1 | Organic compounds | Clariant International Ltd. (CH) | 2010-11-17 | — | — | EP | disclosed |
| EP-2163587-A1 | Acid dyes | CLARIANT INTERNATIONAL LTD. (CH) | 2010-03-17 | — | — | EP | disclosed |
| US-20100000033-A1 | Basic Bisazo Compounds | CLARIANT FINANCE (BVI) LIMITED (VG) | 2010-01-07 | — | — | US | disclosed |
| US-20100000033-A1 | Basic Bisazo Compounds | CLARIANT FINANCE (BVI) LIMITED (VG) | 2010-01-07 | — | — | US | disclosed |
| EP-2078737-A1 | Basic monoazo compounds | Clariant International Ltd. (CH) | 2009-07-15 | — | — | EP | disclosed |
| WO-2008012322-A1 | BASIC BISAZO COMPOUNDS | CLARIANT INTERNATIONAL LTD (CH) | 2008-01-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200172470-A1 | NOVEL (POLY)AMINE COMPOUND, RESIN AND CURED PRODUCT | PAM, CBR1, KDM1A | CYP3A4 1300/4885TDP1 2589/4885ALDH1A1 276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.